Product information and disease description
Place of product in therapy
50 evidence topics · 45 sources
QTORIN rapamycin 3.9 percent gel
Microcystic lymphatic malformations
- Manufacturer
- Palvella Therapeutics
- Regulatory submission
- NDA submitted August 2026
- Last updated